Pediatric patients often experience diseases that are influenced by genetic and epigenetic factors. Conditions such as cancers, neurodevelopmental disorders, and congenital anomalies can be driven by abnormal epigenetic modifications. Epigenetic drugs offer a promising avenue for treating these conditions by normalizing gene expression patterns during critical periods of growth and development.
